Effect of disturbing endocrine drug, DEHP, on microcyst formation in the epithelial cells.
干扰内分泌药物 DEHP 对上皮细胞微囊形成的影响。
基本信息
- 批准号:11680571
- 负责人:
- 金额:$ 2.43万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Vacuolar H^+-ATPase(V-ATPase) is localized in organelles of the central vacuolar system such as lysosomes, coated vesicles, and the Golgi apparatus, and it plays an important role in maintaining the acidic enviroment in these compartments. We investigated the effects of di(2-ethylhexyl) phthalate (DEHP) on mouse liver lysosomes. After 2-3 weeks of oral administration in mice, a reduction in vacuolar H^+-ATPase, as determined by immunocytochemical analysis. When the mice were subsequently fed a normal diet for 1 week, V-ATPase, levels recovered to normal values. According to Northern blot analysis, V-ATPase subunit A mRNA decreased gradually with DEHP treatment. Enzyme cytochemical staining showed acid phosphatase to be present in lysosomes and late autophagosomes in normal animals as well as in DEHP-treated animals. But the number of late autophagosomes containing acid phosphatase increased clearly after DEHP treatment. These results suggest that, DEHP causes marked V-ATPase reduction in the liver lysosomal compartment and the effect to DEHP is reversible, and the effect of DEHP on protein expression is likely to be exerted at the transcriptional level. Thus in this study, we report that DEHP treatment causes a reduction in V-ATPase subunit A in the liver lysosomal compartment, which may accent for the inability to degrade excess cell organelles.
液泡H^+-ATP酶(V-ATPase)定位于中央液泡系统的细胞器,如溶酶体、包被囊泡和高尔基体,在维持这些区室的酸性环境中发挥着重要作用。我们研究了邻苯二甲酸二(2-乙基己基)酯 (DEHP) 对小鼠肝脏溶酶体的影响。小鼠口服给药2-3周后,通过免疫细胞化学分析测定,液泡H^+-ATP酶减少。随后给小鼠喂食正常饮食 1 周后,V-ATP 酶水平恢复至正常值。根据Northern印迹分析,V-ATP酶亚基A mRNA随着DEHP处理逐渐减少。酶细胞化学染色显示酸性磷酸酶存在于正常动物以及经 DEHP 处理的动物的溶酶体和晚期自噬体中。但DEHP处理后含有酸性磷酸酶的晚期自噬体数量明显增加。这些结果表明,DEHP导致肝脏溶酶体区室中V-ATP酶显着减少,并且对DEHP的影响是可逆的,并且DEHP对蛋白质表达的影响可能是在转录水平上发挥的。因此,在这项研究中,我们报告 DEHP 治疗会导致肝脏溶酶体区室中 V-ATP 酶亚基 A 的减少,这可能会加重无法降解多余细胞器的情况。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Wu Y.-X.: "Tyrosine phosphorylation and cellular redistribution of ezrin in MDCK cells treated with pervanadate"J. Cellular Biochemistry. 79. 311-321 (2000)
吴Y.-X.:“过钒酸盐处理的MDCK细胞中酪氨酸磷酸化和埃兹蛋白的细胞重新分布”J。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Wan Tau: "Inhibition effects of DEHP on mouse liver lysosomal V-ATPase."J.Cell.Biochem.. 81. 295-303 (2001)
Wan Tau:“DEHP 对小鼠肝脏溶酶体 V-ATP 酶的抑制作用。”J.Cell.Biochem.. 81. 295-303 (2001)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
UEZATO Tadayoshi其他文献
UEZATO Tadayoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('UEZATO Tadayoshi', 18)}}的其他基金
generation of the HCV-infectable mouse-an animal model for inflammation cancer
HCV感染小鼠的产生——炎症性癌症动物模型
- 批准号:
24659585 - 财政年份:2012
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
相似海外基金
Regulation of mitochondria-lysosome interactions in muscle: effects of age, biological sex and exercise
肌肉中线粒体-溶酶体相互作用的调节:年龄、生物性别和运动的影响
- 批准号:
478339 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别:
Operating Grants
Functional analysis of brain synaptic vesicle and lysosome using model mice of epileptic encephalopathy
癫痫性脑病模型小鼠脑突触小泡和溶酶体的功能分析
- 批准号:
23K06301 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of Lysosome Damage in ALD Pathogenesis
溶酶体损伤在 ALD 发病机制中的作用
- 批准号:
10668006 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别:
Host Defense Small Molecule Development for COVID-19 Treatment by Targeting Lysosome
通过靶向溶酶体治疗 COVID-19 的宿主防御小分子开发
- 批准号:
10735492 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别:
Elucidating the pathogenesis of obesity-related proximal tubulopathy and searching for the therapeutic agents: focus on the lysosome-ferroptosis axis
阐明肥胖相关近端肾小管病变的发病机制并寻找治疗药物:关注溶酶体-铁死亡轴
- 批准号:
23K07671 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel mitochondria-to-lysosome stress signaling pathway in degenerative disease and aging
退行性疾病和衰老中一种新的线粒体到溶酶体应激信号通路
- 批准号:
10722759 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别:
Analysis of lysosome enzymes in pancreatic cancer specific immune evasion system
胰腺癌特异性免疫逃避系统中溶酶体酶的分析
- 批准号:
23K08202 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Novel mitochondria-to-lysosome crosstalk contributes to lysosomal dysfunction during aging
新型线粒体与溶酶体串扰导致衰老过程中溶酶体功能障碍
- 批准号:
10723050 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别:
Defining the Role of Astrocytic Lysosome trafficking and Exocytosis in Regulating Synapse Maturation
定义星形细胞溶酶体运输和胞吐作用在调节突触成熟中的作用
- 批准号:
10677414 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别:
Investigating the Lysosome and Plasma Membrane Systems in Protecting Cells Against Age-induced Amino Acid Toxicity
研究溶酶体和质膜系统保护细胞免受年龄诱导的氨基酸毒性的作用
- 批准号:
10680314 - 财政年份:2023
- 资助金额:
$ 2.43万 - 项目类别: